Milademetan in Advanced/Metastatic Solid Tumors

Clinical trial NCT05012397 · TERMINATED

Trial details

NCT number: NCT05012397
Sponsor: Rain Oncology Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Head and Neck Carcinoma Cholangiocarcinoma Sarcoma Lung Adenocarcinoma Bladder Urothelial Carcinoma Stomach Adenocarcinoma Breast Cancer Invasive Ovarian Carcinoma Cervical Cancer Non Small Cell Lung Cancer Gastric Cancer

Start date: 2021-11-01
Primary completion: 2023-10-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.